Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Poulin

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Journal of Cutaneous Medicine and Surgery|April 30, 2015
Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell CarcinomaMariusz Sapijaszko, David Zloty, Marc Bourcier, et al.
The Journal of Dermatological Treatment|February 6, 2010
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasisYves Poulin, Kim Papp, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|November 19, 2009
A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patientsNorman Wasel, Yves Poulin, Robin Andrew, et al.
Journal of the American Academy of Dermatology|May 25, 2010
Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanerceptRobert Bissonnette, Chantal Bolduc, Yves Poulin, et al.
Journal of the American Academy of Dermatology|March 29, 2011
The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesionsSteven R Feldman, Jerry Tan, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|January 20, 2007
XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Journal of the American Academy of Dermatology|July 15, 2011
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: results from an open-label extension study for patients from REVEALKenneth Gordon, Kim Papp, Yves Poulin, et al.
Alternative Medicine Review : a Journal of Clinical Therapeutic|December 12, 2007
XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Journal of Cutaneous Medicine and Surgery|November 29, 2007
Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratosesJerry K L Tan, D Richard Thomas, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|October 6, 2009
Biologics in the treatment of psoriasis: clinical and economic overviewYves Poulin, Richard G Langley, Henrique D Teixeira, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Journal of Cutaneous Medicine and Surgery|April 30, 2015
Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell CarcinomaMariusz Sapijaszko, David Zloty, Marc Bourcier, et al.
The Journal of Dermatological Treatment|February 6, 2010
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasisYves Poulin, Kim Papp, Robert Bissonnette, et al.
Journal of Cutaneous Medicine and Surgery|November 19, 2009
A Canadian self-administered online survey to evaluate the impact of moderate-to-severe psoriasis among patientsNorman Wasel, Yves Poulin, Robin Andrew, et al.
Journal of the American Academy of Dermatology|May 25, 2010
Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanerceptRobert Bissonnette, Chantal Bolduc, Yves Poulin, et al.
Journal of the American Academy of Dermatology|March 29, 2011
The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesionsSteven R Feldman, Jerry Tan, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|January 20, 2007
XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Journal of the American Academy of Dermatology|July 15, 2011
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: results from an open-label extension study for patients from REVEALKenneth Gordon, Kim Papp, Yves Poulin, et al.
Alternative Medicine Review : a Journal of Clinical Therapeutic|December 12, 2007
XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled studyYves Poulin, Robert Bissonnette, Christina Juneau, et al.
Journal of Cutaneous Medicine and Surgery|November 29, 2007
Efficacy of imiquimod as an adjunct to cryotherapy for actinic keratosesJerry K L Tan, D Richard Thomas, Yves Poulin, et al.
Journal of Cutaneous Medicine and Surgery|October 6, 2009
Biologics in the treatment of psoriasis: clinical and economic overviewYves Poulin, Richard G Langley, Henrique D Teixeira, et al.
Pageof 11